ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 1.61 USD -1.23%
Market Cap: 71.5m USD
Have any thoughts about
ESSA Pharma Inc?
Write Note

ESSA Pharma Inc
Investor Relations

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 30 full-time employees. The firm is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The firm is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. David Ross Parkinson M.D.
President, CEO & Director
No Bio Available
Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA
Chief Financial Officer
No Bio Available
Mr. Peter A. Virsik M.B.A., M.S.
Executive VP & COO
No Bio Available
Dr. Alessandra Cesano M.D., Ph.D.
Chief Medical Officer & Executive VP
No Bio Available
Nkengyal Barber
Executive
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
Suite 2600, 595 Burrard Street
Contacts
+17783310962.0
www.essapharma.com